OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present an update of data from their Phase 2 melanoma study at the American Society of Clinical Oncology’s 50th Annual Meeting, taking place May 30-June 3, 2014, at McCormick Place in Chicago, Illinois. Additional details will be made available on or after May 14, 2014, via the ASCO webpage: http://www.asco.org
Help employers find you! Check out all the jobs and post your resume.
